Impact of endovascular surgery upon standard arterial surgery

BACKGROUND: The aim of this study was to evaluate the impact of endovascular surgery (EVS) upon a standard vascular surgical service. METHODS: Retrospective analysis of all vascular procedures of the last 11 years, the annual number of arterial procedures, the fellows surgical volume as well as the percentage of patients referred to radiology between 1999 (implantation of EVS) and 2003, and the surgical volume of surgeons able to perform both operation and those who perform only standard surgery (SS). RESULTS: An initial decrease in the number of arterial procedures was observed, but recovered after EVS implantation. The percentage of EVS increased from 3.6% in 1999 to 25% in 2003 (p<0.05). There was no decrease in the number of fellows performing SS, yet an increase in their annual number of EVS was observed (2.6 in 1999 and 20 in 2003). All procedures were referred to radiology before 1999 versus none in 2003. Surgeons that perform both operations had an increase in their surgical volume compared to surgeons that perform only SS (p<0.05). CONCLUSION: Without implantation of EVS a decrease of vascular procedures can occur. On the other hand, EVS can lead to a recovery of surgical volume, including an increase in the SS. There was no decrease in the fellows volume of SS, but a improvement in EVS training. Referral of patients to other services can be diminished with EVS implantation. Surgeons that perform both operations have a progressive increase in their volume when compared to those who perform only SS.OBJETIVO: Avaliar o impacto da implantação da cirurgia endovascular (CEV) em um serviço de cirurgia vascular convencional (CVC). MÉTODO: Análise retrospectiva dos procedimentos vasculares nos últimos 11 anos, dos procedimentos arteriais, anuais e por residente, entre 1999 (implantação da CEV) e 2003, e das cirurgias com cirurgiões endovasculares e convencionais e por cirurgiões convencionais apenas. Foi também avaliado o percentual de encaminhamentos das CEV a serviço intervencionista. RESULTADOS: Houve uma queda inicial no número de procedimentos arteriais que foi recuperada após a implantação do serviço de CEV. O percentual das CEV no número total de cirurgias arteriais passou de 3,6% em 1999 para 25% em 2003 (p<0,05). Não houve queda no número de cirurgias convencionais realizadas pelos residentes, mas houve um aumento no número de CEV por residente por ano de 2,6 em 1999 para 20 em 2003. Todas as CEV foram realizadas no nosso próprio serviço em 2003. Houve um aumento do número de cirurgiões que operam por via endovascular e convencional em relação aos que operam apenas por via aberta (p<0.05). CONCLUSÕES: Sem implantação da CEV parece cair o volume de procedimentos globais, mas se mantida dentro do serviço, a CEV pode levar à recuperação, inclusive com aumento das CVC. Não houve prejuízo para o treinamento dos residentes em relação à CVC, e sim a melhora do treinamento em CEV. A implantação da CEV gera um decréscimo no encaminhamento de pacientes. O cirurgião vascular e endovascular têm um volume progressivamente maior comparado com aqueles com treinamento apenas em CVC.2

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism : a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Background: Standard treatment for venous thromboembolism (VTE) consists of a heparin combined with vitamin K antagonists. Direct oral anticoagulants have been investigated for acute and extended treatment of symptomatic VTE; their use could avoid parenteral treatment and/or laboratory monitoring of anticoagulant effects. Methods: A prespecified pooled analysis of the EINSTEIN-DVT and EINSTEIN-PE studies compared the efficacy and safety of rivaroxaban (15 mg twice-daily for 21 days, followed by 20 mg once-daily) with standard-therapy (enoxaparin 1.0 mg/kg twice-daily and warfarin or acenocoumarol). Patients were treated for 3, 6, or 12 months and followed for suspected recurrent VTE and bleeding. The prespecified noninferiority margin was 1.75. Results: 8282 patients were enrolled. 4151 received rivaroxaban and 4131 received standard-therapy. The primary efficacy outcome occurred in 86 rivaroxaban-treated patients (2.1%) compared with 95 (2.3%) standard-therapy-treated patients (hazard ratio, 0.89; 95% confidence interval [CI], 0.66-1.19; pnoninferiority<0.001). Major bleeding was observed in 40 (1.0%) and 72 (1.7%) patients in the rivaroxaban and standard-therapy groups, respectively (hazard ratio, 0.54; 95% CI, 0.37-0.79; p=0.002). In key subgroups, including fragile patients, cancer patients, patients presenting with large clots and those with a history of recurrent VTE, the efficacy and safety of rivaroxaban was similar compared with standard-therapy. Conclusion: The single-drug approach with rivaroxaban resulted in similar efficacy to standard-therapy and was associated with a significantly lower rate of major bleeding. Efficacy and safety results were consistent among key patient subgroups

Rivaroxaban or Aspirin for extended treatment of venous thromboembolism

Background: although many patients with venous thromboembolism require extended treatment, it is uncertain whether it is better to use full- or lower-intensity anticoagulation therapy or aspirin. Methods: in this randomized, double-blind, phase 3 study, we assigned 3396 patients with venous thromboembolism to receive either once-daily rivaroxaban (at doses of 20 mg or 10 mg) or 100 mg of aspirin. All the study patients had completed 6 to 12 months of anticoagulation therapy and were in equipoise regarding the need for continued anticoagulation. Study drugs were administered for up to 12 months. The primary efficacy outcome was symptomatic recurrent fatal or nonfatal venous thromboembolism, and the principal safety outcome was major bleeding. Results: a total of 3365 patients were included in the intention-to-treat analyses (median treatment duration, 351 days). The primary efficacy outcome occurred in 17 of 1107 patients (1.5%) receiving 20 mg of rivaroxaban and in 13 of 1127 patients (1.2%) receiving 10 mg of rivaroxaban, as compared with 50 of 1131 patients (4.4%) receiving aspirin (hazard ratio for 20 mg of rivaroxaban vs. aspirin, 0.34; 95% confidence interval [CI], 0.20 to 0.59; hazard ratio for 10 mg of rivaroxaban vs. aspirin, 0.26; 95% CI, 0.14 to 0.47; P<0.001 for both comparisons). Rates of major bleeding were 0.5% in the group receiving 20 mg of rivaroxaban, 0.4% in the group receiving 10 mg of rivaroxaban, and 0.3% in the aspirin group; the rates of clinically relevant nonmajor bleeding were 2.7%, 2.0%, and 1.8%, respectively. The incidence of adverse events was similar in all three groups. Conclusions: among patients with venous thromboembolism in equipoise for continued anticoagulation, the risk of a recurrent event was significantly lower with rivaroxaban at either a treatment dose (20 mg) or a prophylactic dose (10 mg) than with aspirin, without a significant increase in bleeding rates. (Funded by Bayer Pharmaceuticals; EINSTEIN CHOICE ClinicalTrials.gov number, NCT02064439)

Derivações arteriais abaixo do ligamento inguinal : o uso do doppler ultra-som para realização do teste da papaverina na avaliação per-operatoria e parametros prognosticos de perviedade

Tese (livre-docencia) - Universidade Estadual de Campinas, Faculdade de Ciencias MedicasResumo: Não informadoAbstract: Not informedTese (livre-docencia) - UniverCirurgiaLivre Docente em Ciencias Medica

A incidência regional do tromboembolismo venoso no Brasil

Resumo Contexto Vários estudos realizados em climas temperados sugerem que há uma variação na incidência de tromboembolismo venoso (TEV) de acordo com as estações climáticas. Entretanto, nenhum estudo foi feito comparando áreas de clima semiárido com áreas de clima temperado. Objetivos Analisar se existe correlação entre a incidência do TEV em áreas de clima semiárido e de clima temperado no Brasil. Métodos Foi feito um levantamento de dados retrospectivos de pacientes com diagnóstico de TEV no Sistema Único de Saúde de janeiro de 2011 a dezembro de 2014 provenientes dos seguintes estados com clima semiáridos: Alagoas, Ceará, Maranhão, Paraíba, Pernambuco, Piauí e Rio Grande do Norte, localizados na Região Nordeste do Brasil; e dos seguintes estados com clima temperado: Paraná, Santa Catarina e Rio Grande do Sul, localizados na Região Sul do Brasil. Os dados de variação climática foram obtidos do Instituto Nacional de Meteorologia e os dados populacionais do Instituto Brasileiro de Geografia e Estatística. Resultados Houve correlação significativa na incidência de casos de TEV em regiões de temperaturas mais baixas (p < 0,001). A Região Sul apresentou temperaturas significativamente menores que as da Região Nordeste (p < 0,001) e apresentou número significativamente maior de casos de TEV do que a Região Nordeste (p < 0,001). Conclusão Há mais casos de TEV em regiões de clima temperado, onde as temperaturas são mais baixas. No entanto, pouco ainda é conhecido na literatura sobre a flutuação sazonal e a incidência de TEV. Sendo assim, mais estudos são necessários nessa área

Comparison between the conventional method and a portable device for determination of INR

CONTEXT:Anticoagulation with warfarin is considered the appropriate treatment for venous thromboembolism and other thrombotic pathologies. Regular INR control is required for dosage adjustment and therapeutic control. Use of portable monitoring systems optimizes management of these patients.OBJECTIVE: To compare INR measurements taken using the portable Coaguchek XS system in capillary blood with the standard laboratory method using venous blood.METHOD: Fifty-two samples each of venous and capillary blood were collected from nineteen patients on warfarin, who had been admitted to the Hospital da Beneficência Portuguesa de São Paulo, and analyzed using the conventional method and the Coaguchek XS system, respectively.RESULTS: Spearman's correlation coefficient ® for the overall performance of the two methods was 0.978 (p<0.0001; 95%CI 0.961-0.988). The Kappa measure of agreement for all patients was 76.8% (p<0.001; IC: 95% 0.975-0.561). Mean INR according to the Coaguchek XS system underestimated the values provided by the conventional method by -0.01 INR points, with a standard error of 0.342. Results for INR values greater than 3.5 were satisfactory with a correlation coefficient of 0.71, but without statistical significance (p>0.714).CONCLUSIONS: The Coaguchek XS system can be used to monitor prothrombin time in patients on oral anticoagulants, provided INR values greater than 3.5 are confirmed using the conventional laboratory method

Endovascular treatment of popliteal artery aneurysm. Early and midterm results

OBJECTIVE: to evaluate the efficacy of endovascular repair of popliteal artery aneurysms on maintaining patency of the stent in the short and medium term. METHODS: this was a retrospective, descriptive and analytical study, conducted at the Integrated Vascular Surgery Service at the Hospital da Beneficência Portuguesa de São Paulo. We followed-up 15 patients with popliteal aneurysm, totaling 18 limbs, treated with stent from May 2008 to December 2012. RESULTS: the mean follow-up was 14.8 months. During this period, 61.1% of the stents were patent. The average aneurysm diameter was 2.5cm, ranging from 1.1 to 4.5cm. The average length was 5cm, ranging from 1.5 to 10 cm. In eight cases (47.1%), the lesion crossed the joint line, and in four of these occlusion of the prosthesis occurred. In 66.7% of cases, treatment was elective and only 33.3% were symptomatic patients treated on an emergency basis. The stents used were Viabahn (Gore) in 12 cases (66.7%), Fluency (Bard) in three cases (16.7%), Multilayer (Cardiatis) in two cases (11.1%) and Hemobahn (Gore) in one case (5.6%). In three cases, there was early occlusion (16.6%). During follow-up, 88.2% of patients maintained antiplatelet therapy. There was no leakage at ultrasound (endoleak). No fracture was observed in the stents. CONCLUSION: the results of this study are similar to other published series. Probably, with the development of new devices that support the mechanical characteristics found on the thighs, there will be improved performance and prognosis of endovascular restoration